Abstract A043: Anti-CD19 CAR T-cells with a CRISPR/Cas9-mediated T-cell receptor knockout show high functionality in the absence of alloreactivity in vitro
Dana Stenger(German Cancer Research Center), Tobias Feuchtinger(University of Freiburg), Sebastian Kobold(German Cancer Research Center), Franziska Blaeschke(German Cancer Research Center), Dirk H. Busch(German Center for Infection Research), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Theresa Käuferle(German Center for Infection Research), Ramin Lotfi(German Red Cross), Semjon Willier(Ludwig-Maximilians-Universität München), Beate Wagner(München Klinik), Tanja A. Stief(Ludwig-Maximilians-Universität München), Felicitas Rataj(Center for Integrated Protein Science Munich)
Cited by 0
Related Papers
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
|Nature Communications|2016|727
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
|European Journal of Immunology|2021|506